Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections [clinicaltrials:NCT00174811]

Bio2RDF uri

Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections [clinicaltrials:NCT00174811]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00174811

Bio2RDF identifier

NCT00174811

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00174811

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00174811

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

639

http://www.w3.org/2001/XMLSchema#integer

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:d942c8692d257084abf3ac87279faff6

brief summary [clinicaltrials_vocabulary:brief-summary]

The clinical activity o ...... 9 months old will be studied.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Comparative Study to Evaluate ...... ren With Middle Ear Infections

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Clinical cure at the posttherapy/test-of-cure (TOC) Visit 3 (Day 13-17). [clinicaltrials_resource:a25b7566936301020255f66fe56c3ed3]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Clinical cure at the posttherapy/test-of-cure (TOC) Visit 3 (Day 13-17). [clinicaltrials_resource:648947fb347c32b924063032c53ff328]

Clinical cure at the posttherapy/test-of-cure (TOC) Visit 3 (Day 13-17). [clinicaltrials_resource:6842cfb35675df71b18baad48092a84b]

Clinical cure at the posttherapy/test-of-cure (TOC) Visit 3 (Day 13-17). [clinicaltrials_resource:86c042deef5bca6c7e1683043b4f978c]

Clinical cure at the posttherapy/test-of-cure (TOC) Visit 3 (Day 13-17). [clinicaltrials_resource:8af222c4c752bebe975bd06bf5f8ca33]

Clinical cure at the posttherapy/test-of-cure (TOC) Visit 3 (Day 13-17). [clinicaltrials_resource:8c7abaef5523b533403ccf08980387d6]

Clinical cure at the posttherapy/test-of-cure (TOC) Visit 3 (Day 13-17). [clinicaltrials_resource:c61112d8e5e4db93e751dcb13b8180b8]

completion date [clinicaltrials_vocabulary:completion-date]

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00174811 [clinicaltrials_resource:1dd59a13ec1090fc21f282d4477d1779]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

telithromycin (HMR3647) [clinicaltrials_resource:0aca66dc50a79f805ca2fcd8928bbf67]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Cefuroxime axetil [clinicaltrials_resource:067dbcc26185fa56b0b8a49b4b6f1527]

Cefuroxime [clinicaltrials_resource:8f9ce7ffdf4396dbeabff8ad91ccc431]

Telithromycin [clinicaltrials_resource:9832908715e58012ecf6f8f092436113]

keyword [clinicaltrials_vocabulary:keyword]

acute otitis media

http://www.w3.org/2001/XMLSchema#string

cefuroxime axetil

http://www.w3.org/2001/XMLSchema#string

controlled clinical trial

http://www.w3.org/2001/XMLSchema#string

middle ear infections

http://www.w3.org/2001/XMLSchema#string

telithromycin

http://www.w3.org/2001/XMLSchema#string

tympanocentecis

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2009-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Sanofi [clinicaltrials_resource:26fba9456e1e33d5671ff7055ed23621]

location [clinicaltrials_vocabulary:location]

Sanofi-Aventis Administrative Office [clinicaltrials_resource:efeb8060aef6b3a2630a25eb01e67ca8]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00174811

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

Multinational, Randomized, Dou ...... ildren With Acute Otitis Media

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

EFC6131

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

ICD CSD [clinicaltrials_resource:cda47c127f90587e0df1c2f2a1f35c48]

overall status [clinicaltrials_vocabulary:overall-status]

Terminated [clinicaltrials_resource:fba9c4daa2dd29d1077d32d965320ac1]

oversight [clinicaltrials_vocabulary:oversight]

United States: Food and Drug Administration [clinicaltrials_resource:dcb211c7d2db576694486f430422970c]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

ICD Study Director, sanofi-aventis [clinicaltrials_resource:b2a660a63f7830cd3a26c1a777904417]

secondary id [clinicaltrials_vocabulary:secondary-id]

HMR3647B/3001

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

Sanofi [clinicaltrials_resource:26fba9456e1e33d5671ff7055ed23621]

start date [clinicaltrials_vocabulary:start-date]

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00174811 study design [clinicaltrials_resource:4a048786f28d2e13c06fd11689651cb3]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00174811

verification date [clinicaltrials_vocabulary:verification-date]

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

why stopped [clinicaltrials_vocabulary:why-stopped]

Pediatric development program terminated by sponsor

http://www.w3.org/2001/XMLSchema#string

identifier

clinicaltrials:NCT00174811

http://www.w3.org/2001/XMLSchema#string

title

Comparative Study to Evaluate ...... ren With Middle Ear Infections

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Comparative Study to Evaluate ...... s [clinicaltrials:NCT00174811]

@en